{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:53:36Z","timestamp":1790801616412,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Biofilms Microbiomes"],"DOI":"10.1038\/s41522-025-00706-w","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T08:47:49Z","timestamp":1751359669000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Targeted metabolomics reveals bioactive inflammatory mediators from gut into blood circulation in children with NAFLD"],"prefix":"10.1038","volume":"11","author":[{"given":"Miyang","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayou","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atipatsa C.","family":"Kaminga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongfeng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"706_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.80","volume":"1","author":"EM Brunt","year":"2015","unstructured":"Brunt, E. M. et al. Nonalcoholic fatty liver disease. Nat. Rev. Dis. Prim. 1, 15080 (2015).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"706_CR2","doi-asserted-by":"publisher","first-page":"e042843","DOI":"10.1136\/bmjopen-2020-042843","volume":"11","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. Increasing prevalence of NAFLD\/NASH among children, adolescents and young adults from 1990 to 2017: a population-based observational study. BMJ Open 11, e042843 (2021).","journal-title":"BMJ Open"},{"key":"706_CR3","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1467-789X.2009.00657.x","volume":"11","author":"G Musso","year":"2010","unstructured":"Musso, G., Gambino, R. & Cassader, M. Non-alcoholic fatty liver disease from pathogenesis to management: an update. Obes. Rev.11, 430\u2013445 (2010).","journal-title":"Obes. Rev."},{"key":"706_CR4","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/s41575-021-00502-9","volume":"18","author":"M Masoodi","year":"2021","unstructured":"Masoodi, M. et al. Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests. Nat. Rev. Gastroenterol. Hepatol. 18, 835\u2013856 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"706_CR5","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1053\/j.gastro.2020.01.049","volume":"158","author":"J Aron-Wisnewsky","year":"2020","unstructured":"Aron-Wisnewsky, J., Warmbrunn, M. V., Nieuwdorp, M. & Cl\u00e9ment, K. Nonalcoholic fatty liver disease: modulating gut microbiota to improve severity?. Gastroenterology 158, 1881\u20131898 (2020).","journal-title":"Gastroenterology"},{"key":"706_CR6","doi-asserted-by":"crossref","unstructured":"Sztolsztener, K., Chabowski, A., Harasim-Symbor, E., Bielawiec, P. & Konstantynowicz-Nowicka, K. Arachidonic acid as an early indicator of inflammation during non-alcoholic fatty liver disease development. Biomolecules 10, 1133 (2020).","DOI":"10.3390\/biom10081133"},{"key":"706_CR7","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1002\/hep.31115","volume":"72","author":"L Ma","year":"2020","unstructured":"Ma, L. et al. Indole alleviates diet-induced hepatic steatosis and inflammation in a manner involving myeloid cell 6-Phosphofructo-2-Kinase\/Fructose-2,6-Biphosphatase 3. Hepatology 72, 1191\u20131203 (2020).","journal-title":"Hepatology"},{"key":"706_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104009","volume":"142","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. Contribution of endotoxin to Th17 bias in patients with non-alcoholic steatohepatitis. Micro. Pathog. 142, 104009 (2020).","journal-title":"Micro. Pathog."},{"key":"706_CR9","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1210\/clinem\/dgab538","volume":"106","author":"RG Cosentino","year":"2021","unstructured":"Cosentino, R. G. et al. Branched-chain amino acids and relationship with inflammation in youth with obesity: a randomized controlled intervention study. J. Clin. Endocrinol. Metab. 106, 3129\u20133139 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"706_CR10","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/MCO.0000000000000584","volume":"22","author":"C Knudsen","year":"2019","unstructured":"Knudsen, C., Neyrinck, A. M., Lanthier, N. & Delzenne, N. M. Microbiota and nonalcoholic fatty liver disease: promising prospects for clinical interventions?. Curr. Opin. Clin. Nutr. Metab. Care 22, 393\u2013400 (2019).","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"706_CR11","first-page":"1198","volume":"54","author":"MH Ali","year":"2016","unstructured":"Ali, M. H., Messiha, B. A. & Abdel-Latif, H. A. Protective effect of ursodeoxycholic acid, resveratrol, and N-acetylcysteine on nonalcoholic fatty liver disease in rats. Pharm. Biol. 54, 1198\u20131208 (2016).","journal-title":"Pharm. Biol."},{"key":"706_CR12","doi-asserted-by":"crossref","unstructured":"Ji, Y., Yin, Y., Li, Z. & Zhang, W. Gut microbiota-derived components and metabolites in the progression of non-alcoholic fatty liver disease (NAFLD). Nutrients 11, 1712 (2019).","DOI":"10.3390\/nu11081712"},{"key":"706_CR13","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1136\/gutjnl-2021-325189","volume":"71","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. Integrative metabolomic characterisation identifies altered portal vein serum metabolome contributing to human hepatocellular carcinoma. Gut 71, 1203\u20131213 (2022).","journal-title":"Gut"},{"key":"706_CR14","doi-asserted-by":"crossref","unstructured":"Garcia, B. et al. Effects of branched-chain amino acids on the inflammatory response induced by LPS in Caco-2 Cells. Metabolites 14, 76 (2024).","DOI":"10.3390\/metabo14010076"},{"key":"706_CR15","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00726-014-1894-9","volume":"47","author":"AD Lake","year":"2015","unstructured":"Lake, A. D. et al. Branched chain amino acid metabolism profiles in progressive human nonalcoholic fatty liver disease. Amino Acids 47, 603\u2013615 (2015).","journal-title":"Amino Acids"},{"key":"706_CR16","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1053\/j.gastro.2010.06.064","volume":"139","author":"J Westerbacka","year":"2010","unstructured":"Westerbacka, J. et al. Splanchnic balance of free fatty acids, endocannabinoids, and lipids in subjects with nonalcoholic fatty liver disease. Gastroenterology 139, 1961\u20131971.e1961 (2010).","journal-title":"Gastroenterology"},{"key":"706_CR17","doi-asserted-by":"crossref","unstructured":"Misheva, M., Johnson, J. & McCullagh, J. Role of oxylipins in the inflammatory-related diseases NAFLD, obesity, and Type 2 diabetes. Metabolites 12, 1238 (2022).","DOI":"10.3390\/metabo12121238"},{"key":"706_CR18","doi-asserted-by":"crossref","unstructured":"Ferrer, M. D. et al. Polyunsaturated and saturated oxylipin plasma levels allow monitoring the non-alcoholic fatty liver disease progression to severe stages. Antioxidants 12, 711 (2023).","DOI":"10.3390\/antiox12030711"},{"key":"706_CR19","doi-asserted-by":"publisher","first-page":"5214","DOI":"10.3390\/ijms21155214","volume":"21","author":"J Chen","year":"2020","unstructured":"Chen, J. & Vitetta, L. Gut Microbiota metabolites in NAFLD Pathogenesis and therapeutic implications. Int. J. Mol. Sci. 21, 5214 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"706_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.1089359","volume":"9","author":"H Bing","year":"2022","unstructured":"Bing, H. & Li, Y. L. The role of bile acid metabolism in the occurrence and development of NAFLD. Front. Mol. Biosci. 9, 1089359 (2022).","journal-title":"Front. Mol. Biosci."},{"key":"706_CR21","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","volume":"14","author":"NE Sunny","year":"2011","unstructured":"Sunny, N. E., Parks, E. J., Browning, J. D. & Burgess, S. C. Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. Cell Metab. 14, 804\u2013810 (2011).","journal-title":"Cell Metab."},{"key":"706_CR22","doi-asserted-by":"publisher","first-page":"E311","DOI":"10.1152\/ajpendo.00161.2015","volume":"309","author":"NE Sunny","year":"2015","unstructured":"Sunny, N. E. et al. Cross-talk between branched-chain amino acids and hepatic mitochondria is compromised in nonalcoholic fatty liver disease. Am. J. Physiol. Endocrinol. Metab. 309, E311\u2013E319 (2015).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"706_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0378-4347(00)00105-5","volume":"746","author":"T Ohie","year":"2000","unstructured":"Ohie, T., Fu, X., Iga, M., Kimura, M. & Yamaguchi, S. Gas chromatography-mass spectrometry with tert.-butyldimethylsilyl derivation: use of the simplified sample preparations and the automated data system to screen for organic acidemias. J. Chromatogr. B Biomed. Sci. Appl. 746, 63\u201373 (2000).","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"706_CR24","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000243739","volume":"61","author":"V Walker","year":"1992","unstructured":"Walker, V. & Mills, G. A. Effects of birth asphyxia on urinary organic acid excretion. Biol. Neonate 61, 162\u2013172 (1992).","journal-title":"Biol. Neonate"},{"key":"706_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-61290-x","volume":"10","author":"B Zhou","year":"2020","unstructured":"Zhou, B., Lou, B., Liu, J. & She, J. Serum metabolite profiles as potential biochemical markers in young adults with community-acquired pneumonia cured by moxifloxacin therapy. Sci. Rep. 10, 4436 (2020).","journal-title":"Sci. Rep."},{"key":"706_CR26","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jhep.2021.10.013","volume":"76","author":"PK Luukkonen","year":"2022","unstructured":"Luukkonen, P. K. et al. Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease. J. Hepatol. 76, 526\u2013535 (2022).","journal-title":"J. Hepatol."},{"key":"706_CR27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.mam.2017.06.001","volume":"56","author":"M Li","year":"2017","unstructured":"Li, M., Cai, S. Y. & Boyer, J. L. Mechanisms of bile acid mediated inflammation in the liver. Mol. Asp. Med. 56, 45\u201353 (2017).","journal-title":"Mol. Asp. Med."},{"key":"706_CR28","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1007\/s10620-015-3776-8","volume":"60","author":"BC Ferslew","year":"2015","unstructured":"Ferslew, B. C. et al. Altered bile acid metabolome in patients with nonalcoholic steatohepatitis. Dig. Dis. Sci. 60, 3318\u20133328 (2015).","journal-title":"Dig. Dis. Sci."},{"key":"706_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.849767","volume":"9","author":"H Jian","year":"2022","unstructured":"Jian, H. et al. Amino acid and fatty acid metabolism disorders trigger oxidative stress and inflammatory response in excessive dietary valine-induced NAFLD of Laying Hens. Front. Nutr. 9, 849767 (2022).","journal-title":"Front. Nutr."},{"key":"706_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2022.100709","volume":"27","author":"JJ Cook","year":"2022","unstructured":"Cook, J. J. et al. Endurance exercise-mediated metabolic reshuffle attenuates high-caloric diet-induced non-alcoholic fatty liver disease. Ann. Hepatol. 27, 100709 (2022).","journal-title":"Ann. Hepatol."},{"key":"706_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.8971","volume":"35","author":"F Yu","year":"2021","unstructured":"Yu, F. et al. Exploring the metabolic phenotypes associated with different host inflammation of acute respiratory distress syndrome (ARDS) from lung metabolomics in mice. Rapid Commun. Mass Spectrom. 35, e8971 (2021).","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"706_CR32","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.3389\/fimmu.2019.01462","volume":"10","author":"A Viola","year":"2019","unstructured":"Viola, A., Munari, F., S\u00e1nchez-Rodr\u00edguez, R., Scolaro, T. & Castegna, A. The metabolic signature of macrophage responses. Front. Immunol. 10, 1462 (2019).","journal-title":"Front. Immunol."},{"key":"706_CR33","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.celrep.2019.06.018","volume":"28","author":"JD Bailey","year":"2019","unstructured":"Bailey, J. D. et al. Nitric oxide modulates metabolic remodeling in inflammatory macrophages through TCA cycle regulation and itaconate accumulation. Cell Rep. 28, 218\u2013230.e217 (2019).","journal-title":"Cell Rep."},{"key":"706_CR34","doi-asserted-by":"publisher","first-page":"14832","DOI":"10.1096\/fj.202001495R","volume":"34","author":"MS Muyyarikkandy","year":"2020","unstructured":"Muyyarikkandy, M. S. et al. Branched chain amino acids and carbohydrate restriction exacerbate ketogenesis and hepatic mitochondrial oxidative dysfunction during NAFLD. Faseb J. 34, 14832\u201314849 (2020).","journal-title":"Faseb J."},{"key":"706_CR35","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1002\/hep.30097","volume":"68","author":"L Goedeke","year":"2018","unstructured":"Goedeke, L. et al. Acetyl-CoA carboxylase inhibition reverses NAFLD and hepatic insulin resistance but promotes hypertriglyceridemia in rodents. Hepatology 68, 2197\u20132211 (2018).","journal-title":"Hepatology"},{"key":"706_CR36","doi-asserted-by":"crossref","unstructured":"Fletcher, J. A. et al. Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver. JCI insight 4, e127737 (2019).","DOI":"10.1172\/jci.insight.127737"},{"key":"706_CR37","doi-asserted-by":"crossref","unstructured":"Huang, J. et al. Effect of curcumin on regulatory B cells in chronic colitis mice involving TLR\/MyD88 signaling pathway. Phytother. Res. 37, 731\u2013742 (2022).","DOI":"10.1002\/ptr.7656"},{"key":"706_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2180-4-33","volume":"4","author":"T Tallant","year":"2004","unstructured":"Tallant, T. et al. Flagellin acting via TLR5 is the major activator of key signaling pathways leading to NF-kappa B and proinflammatory gene program activation in intestinal epithelial cells. BMC Microbiol. 4, 33 (2004).","journal-title":"BMC Microbiol."},{"key":"706_CR39","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.celrep.2018.03.109","volume":"23","author":"S Krishnan","year":"2018","unstructured":"Krishnan, S. et al. Gut Microbiota-Derived Tryptophan metabolites modulate inflammatory response in hepatocytes and macrophages. Cell Rep. 23, 1099\u20131111 (2018).","journal-title":"Cell Rep."},{"key":"706_CR40","doi-asserted-by":"publisher","first-page":"fj201800544","DOI":"10.1096\/fj.201800544","volume":"32","author":"M Beaumont","year":"2018","unstructured":"Beaumont, M. et al. The gut microbiota metabolite indole alleviates liver inflammation in mice. Faseb J. 32, fj201800544 (2018).","journal-title":"Faseb J."},{"key":"706_CR41","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.cmet.2018.07.001","volume":"28","author":"JM Natividad","year":"2018","unstructured":"Natividad, J. M. et al. Impaired aryl hydrocarbon receptor ligand production by the gut microbiota is a key factor in metabolic syndrome. Cell Metab. 28, 737\u2013749.e734 (2018).","journal-title":"Cell Metab."},{"key":"706_CR42","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.immuni.2014.06.014","volume":"41","author":"M Venkatesh","year":"2014","unstructured":"Venkatesh, M. et al. Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4. Immunity 41, 296\u2013310 (2014).","journal-title":"Immunity"},{"key":"706_CR43","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/hep.29465","volume":"67","author":"M Gaggini","year":"2018","unstructured":"Gaggini, M. et al. Altered amino acid concentrations in NAFLD: impact of obesity and insulin resistance. Hepatology 67, 145\u2013158 (2018).","journal-title":"Hepatology"},{"key":"706_CR44","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/JCI23621","volume":"115","author":"KL Donnelly","year":"2005","unstructured":"Donnelly, K. L. et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Investig. 115, 1343\u20131351 (2005).","journal-title":"J. Clin. Investig."},{"key":"706_CR45","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1002\/hep.26225","volume":"57","author":"LP Bechmann","year":"2013","unstructured":"Bechmann, L. P. et al. Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis. Hepatology 57, 1394\u20131406 (2013).","journal-title":"Hepatology"},{"key":"706_CR46","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.1210\/jc.2017-01397","volume":"102","author":"V Legry","year":"2017","unstructured":"Legry, V. et al. Bile acid alterations are associated with insulin resistance, but not with NASH, in Obese Subjects. J. Clin. Endocrinol. Metab. 102, 3783\u20133794 (2017).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"706_CR47","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.numecd.2016.03.013","volume":"26","author":"S Haufe","year":"2016","unstructured":"Haufe, S. et al. Branched-chain and aromatic amino acids, insulin resistance and liver specific ectopic fat storage in overweight to obese subjects. Nutr. Metab. Cardiovasc. Dis. 26, 637\u2013642 (2016).","journal-title":"Nutr. Metab. Cardiovasc. Dis."}],"container-title":["npj Biofilms and Microbiomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41522-025-00706-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-025-00706-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-025-00706-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T08:47:52Z","timestamp":1751359672000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41522-025-00706-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["706"],"URL":"https:\/\/doi.org\/10.1038\/s41522-025-00706-w","relation":{},"ISSN":["2055-5008"],"issn-type":[{"value":"2055-5008","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"9 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"119"}}